uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
Show others and affiliations
2015 (English)In: Journal of Clinical Investigation, ISSN 0021-9738, E-ISSN 1558-8238, Vol. 125, no 4, 1739-1751 p.Article in journal (Refereed) Published
Abstract [en]

Decreased insulin sensitivity, also referred to as insulin resistance (IR), is a fundamental abnormality in patients with type 2 diabetes and a risk factor for cardiovascular disease. While IR predisposition is heritable, the genetic basis remains largely unknown. The GENEticS of Insulin Sensitivity consortium conducted a genome-wide association study (GWAS) for direct measures of insulin sensitivity, such as euglycemic clamp or insulin suppression test, in 2,764 European individuals, with replication in an additional 2,860 individuals. The presence of a nonsynonymous variant of N-acetyltransferase 2 (NAT2) [rs1208 (803A>G, K268R)] was strongly associated with decreased insulin sensitivity that was independent of BMI. The rs1208 "A" allele was nominally associated with IR-related traits, including increased fasting glucose, hemoglobin A1C, total and LDL cholesterol, triglycerides, and coronary artery disease. NAT2 acetylates arylamine and hydrazine drugs and carcinogens, but predicted acetylator NAT2 phenotypes were not associated with insulin sensitivity. In a murine adipocyte cell line, silencing of NAT2 ortholog Nat1 decreased insulin-mediated glucose uptake, increased basal and isoproterenol-stimulated lipolysis, and decreased adipocyte differentiation, while Nat1 overexpression produced opposite effects. Nat1-deficient mice had elevations in fasting blood glucose, insulin, and triglycerides and decreased insulin sensitivity, as measured by glucose and insulin tolerance tests, with intermediate effects in Nat1 heterozygote mice. Our results support a role for NAT2 in insulin sensitivity.

Place, publisher, year, edition, pages
2015. Vol. 125, no 4, 1739-1751 p.
National Category
Other Medical Sciences not elsewhere specified
URN: urn:nbn:se:uu:diva-252190DOI: 10.1172/JCI74592ISI: 000352248600037PubMedID: 25798622OAI: oai:DiVA.org:uu-252190DiVA: diva2:810099

De sista fem författarna delar sistaförfattarskapet.

Available from: 2015-05-06 Created: 2015-05-04 Last updated: 2016-01-25Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lind, LarsIngelsson, Erik
By organisation
Molecular epidemiologyScience for Life Laboratory, SciLifeLabCardiovascular epidemiology
In the same journal
Journal of Clinical Investigation
Other Medical Sciences not elsewhere specified

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 201 hits
ReferencesLink to record
Permanent link

Direct link